Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Can Fite Biopharma Ltd

CANF ✓ COMPLIANT ☆ Track — members

NYSE American · Healthcare · Pharmaceuticals ·

USA Micro Cap Analyst: BUY

Last Close

$3.40

▲ +0.00%

Market Cap $7.63M · Vol 2.33K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$7.63M

Micro Cap

Div Yield

N/A

EPS Growth

+100.00%

YoY

RSI (14)

59.69

Momentum

Beta

1.13

vs Market

52W High

$13.56

74.93% below

52W Low

$2.57

32.30% above

Volume

2.33K

Avg 8.49K

P/B

0.01

Price-to-book

ROE

N/A

Return on equity

Free Float

100.00%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Can Fite Biopharma Ltd (CANF) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does CANF pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-1.16%

+5.59%

-2.58%

-24.94%

YTD

-15.00%

-74.70%

-93.66%

-99.12%

Financials & Valuation

TTM · Annual

Total Revenue	N/A
Net Income	N/A
Revenue Growth (YoY)	N/A
Gross Margin	100.00%
Operating Margin	-2,456.79%
Net Profit Margin	-2,426.67%
ROE	N/A
ROA · ROIC	N/A · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	0.05
P/B	0.01
P/FCF	N/A
EPS Growth	+100.00%
Outstanding Shares	4.29M

Technical Indicators

50-Day SMA	$3.22
200-Day SMA	$4.25
RSI (14)	59.69
Beta	1.13
52-Week High	$13.56
52-Week Low	$2.57

Volume Today	2.33K
Avg Daily Volume (30D)	8.49K
Relative Volume	0.27x
Volatility (10D)	69.64
Volatility (30D)	56.84
Free Float	100.00%

Analyst Consensus

BUY

Current Price $3.40

Mean Target $50.00

52W Low$2.57 52W High$13.56

Current

Target

$2.57 $13.56

Current Analyst target

+1,370.59% upside potential · 1 analysts

Identifiers

ExchangeNYSE American

FIGIBBG003CMFFC8

ISINUS13471N4097

CountryIsrael

Sub-IndustryBiopharmaceuticals

Earnings DateN/A

TypeStocks

Instrument TypeADR American Depositary Receipt

Similar Halal Stocks

REGN Regeneron Pharmaceuticals Inc -0.31% 207940.KS Samsung Biologics Co Ltd -1.02% UCB.BR Ucb SA -3.10% CSL.AX CSL Ltd -0.74% BIIB Biogen Inc -0.39%

Company Profile

Can Fite Biopharma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. Its technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.